Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2019 Nov 17;67(2):e28064. doi: 10.1002/pbc.28064

Cognitive Mediators of Adaptive Functioning Outcomes in Survivors of Pediatric Brain Tumors Treated With Proton Radiotherapy

Alexandra K Roth 1, M Douglas Ris 1, Jessica Orobio 1, Judy Xue 1, Anita Mahajan 2, Arnold C Paulino 3, David Grosshans 3, M Fatih Okcu 4, Murali Chintagumpala 4, Lisa Kahalley 1
PMCID: PMC7433211  NIHMSID: NIHMS1612741  PMID: 31736188

Abstract

Background:

Cranial radiotherapy (RT) is associated with risk for cognitive and adaptive dysfunction. Proton RT (PRT) is a technique hypothesized to spare cognition by reducing exposure to non-target brain tissue. However, little is known regarding functional outcomes in survivors of pediatric brain tumor (BT) treated with PRT. The present study examined the relationship between cognitive and adaptive outcomes in pediatric BT survivors post-PRT.

Methods:

Survivors treated with either focal (n = 33) or craniospinal (CSI; n = 37) PRT completed neurocognitive evaluations approximately 5 years post-treatment. Results of intelligence testing and ratings of adaptive functioning are reported. Mediation models examined the relationship among radiation field, cognition, and adaptive functioning.

Results:

The PRT CSI group demonstrated worse cognitive outcomes than the PRT Focal group across each cognitive index (Cohen’s d = .56 to .70). Parent ratings of adaptive functioning were also worse in the PRT CSI group than the PRT Focal group (Global Adaptive Composite, d = .53; Conceptual skills, d = .67). Cognitive performance fully mediated the relationship between radiation field and adaptive outcomes, while controlling for group differences in tumor histology and RT dose.

Conclusions:

Focal PRT survivors demonstrated generally positive outcomes with weaknesses in processing speed and aspects of adaptive functioning. CSI exposure was associated with more consistently poor cognitive and adaptive outcomes. The increased risk for adaptive dysfunction in the PRT CSI group appeared due to the effects of CSI on cognition. Efforts to reduce the volume of tissue exposure to RT remain important.

Keywords: brain tumor, proton radiation, adaptive functioning, functional outcome

Introduction

Pediatric brain tumor survivors are at risk for not only suboptimal neurocognitive outcomes but also worsened adaptive functioning (13). Adaptive functioning refers to the practical, conceptual, and critical social skills necessary for independent living (4). Poor adaptive functioning has negative implications for future employment, independent living, personal care, and interpersonal relationships. Cranial radiotherapy (RT), and craniospinal irradiation (CSI) in particular, are associated with neurocognitive “late effects,” including declines in full scale IQ as well as attention, working memory, and processing speed (3, 56). However, relatively little is known regarding the effects of radiation, particularly proton radiation, on adaptive functioning and, to a lesser extent, the association of adaptive functioning with neurocognitive outcomes.

Weaknesses in adaptive functioning have been consistently documented among survivors of pediatric brain tumors (2, 79). Even when adaptive functioning has been reported to fall within a normative range, performance has differed significantly from healthy controls, normative means, and rates of impairment expected in the general population (1, 1013). A number of clinical variables have been associated with worse adaptive functioning outcomes, including tumor size and location, age at diagnosis, time since treatment, and exposure to RT (7, 11, 14). Additionally, there is initial evidence within the broad pediatric literature to suggest that the relationship between clinical risk factors and adaptive outcomes may be mediated by cognitive functioning (1517).

Advances in radiotherapy (e.g., intensity modulated RT, particle therapy) have the promise to optimize treatment outcomes while minimizing undesired side effects in pediatric brain tumor survivors. Compared to conventional photon (or x-ray) RT (XRT), proton RT (PRT) has been hypothesized to spare cognitive abilities by reducing radiation exposure to non-target brain tissue. Early findings, thus far, appear promising for potential benefits of PRT compared to modern XRT techniques in terms of preservation of neurocognitive function (1824). However, because of the historically limited availability of PRT, the literature on adaptive outcomes following PRT is sparse. In the only published study we identified, Pulsifer and colleagues (25) reported on a diagnostically heterogeneous sample of pediatric brain tumor patients treated with PRT (n=155). They found adaptive functioning to fall within the average range at baseline and at three years post-PRT with no significant change in functioning over time. Worse adaptive functioning at baseline was associated with hydrocephalus and sensorimotor deficits. Adaptive and IQ scores were correlated at baseline.

The aim of the current study was to examine cognitive and adaptive outcomes in a diverse cohort of pediatric brain tumor survivors treated with PRT. Specifically, we hypothesized that individuals treated with CSI PRT were at an increased risk for adaptive dysfunction relative to those treated with focal PRT, consistent with the broader literature on XRT and cognition. We also explored whether cognitive functioning would mediate the association between radiation field (CSI or focal) and adaptive outcomes.

Methods

Participants and procedures

Data presented here are part of a larger study investigating long-term neurocognitive outcomes in pediatric brain tumor survivors. The study was approved by the Institutional Review Board (IRB). Eligible study participants were identified by medical chart review and consecutively enrolled. Written informed consent was obtained prior to participation.

Eligible survivors were between the ages of 5 and 20 with a history of a brain tumor treated with PRT at least one year prior to enrollment and with no evidence of active disease. All patients spoke either English or Spanish. Patients diagnosed with brain stem gliomas, high-grade gliomas, and atypical teratoid/rhabdoid tumors were excluded from participation due to our interest in long-term outcomes. The present study describes outcomes of 70 identified survivors with completed measures of adaptive functioning and neuropsychological testing at a single time point between 2011 and 2017.

Measures

Wechsler Intelligence Scale

Participants were administered the age-appropriate Wechsler Scales of Intelligence (2631) in English or Spanish. Performance yields five summary scores. The Verbal Comprehension Index (VCI) assesses verbal reasoning skills and involves tasks such as defining vocabulary terms and explaining how two concepts are alike. The Perceptual Reasoning Index (PRI) assesses visual-spatial and picture-based reasoning skills and involves recreating block designs and identifying patterns. The Working Memory Index (WMI) assesses brief attention and short-term memory and involves remembering and sequencing auditory and visual information. The Processing Speed Index (PSI) assesses speeded responses on tasks requiring visual scanning and motor responses. Finally, performance across all measures is summarized by the Full Scale IQ (FSIQ) score. Scores are reported as age-corrected standard scores with a mean (M) of 100 and a standard deviation (SD) of 15; lower scores represent worse performance.

Adaptive Behavior Assessment System

Adaptive functioning was assessed using the Adaptive Behavior Assessment System, Second Edition (ABAS-II; 32) or Third Edition (ABAS-3; 33). The two editions are highly correlated with corrected r values across adaptive domains ranging from .83 to .88 (33). The ABAS is a standardized, written questionnaire intended to be completed by parents or caregivers that measures adaptive behaviors necessary for independent functioning across home, school, and community settings. It is published in English and Spanish for ages 0 to 89 years. Nine subscales are summarized across four composite scores, including the Global Adaptive Composite (GAC), Conceptual Domain, Social Domain, and Practical Domain. The Conceptual Domain summarizes skills related to communication, self-direction, and functional academics. The Social Domain summarizes skills related to social and leisure functioning. The Practical Domain summarizes skills related to community use, home living, health and safety, and self-care. Lower standard scores (M = 100, SD = 15) represent weaker adaptive behaviors and reduced functional independence.

Statistical Analyses

The demographic and medical characteristics of survivors treated with CSI or focal PRT were compared using t tests and chi square analyses. Performance on cognitive tests and ratings of adaptive functioning were compared across the PRT CSI and Focal groups using independent groups t tests. One-sample t tests were also used to compare cognitive performance and adaptive functioning to each measure’s respective normative mean. Pearson correlations were used to identify significant relationships between cognitive and adaptive outcomes. Finally, mediation models were used to assess whether radiation field had a direct effect on adaptive functioning or was instead mediated by cognitive performance.

A mediation hypothesis can be tested using a series of three regression models describing the relationship among independent, dependent, and mediating variables (See Figure 1; 34). In the current study, the independent variable was defined as radiation field (i.e., CSI or focal PRT). The dependent variables were adaptive functioning outcomes measured by the ABAS index scores, and the mediating variables were cognitive performance across Wechsler index scores. The three regression models are completed in sequential order.

  1. The first regression model (path c) determines whether the independent variable (PRT radiation field) is a significant predictor of the dependent variable (adaptive functioning). If there is not a significant relationship, the analysis ends; if there is a significant relationship, a second regression is run.

  2. The second regression model (path a) assesses the relationship between the independent variable and the mediating variable (i.e., PRT radiation field and cognitive functioning). Again, if there are no significant findings, the analysis ends; otherwise, a third and final regression model is run.

  3. The third model (paths b and c’) includes both the independent and mediating variables predicting the dependent variable (adaptive functioning).

Figure 1.

Figure 1

Visual representation of mediation models and pathways

A mediation model can be tested using three regression analyses. The first regression tests path c, which represents the total effect of an independent variable (i.e., PRT field: CSI or Focal) on a dependent variable (i.e., adaptive functioning). If there is a significant relationship, a second regression tests path a. Path a represents the effect of the independent variable on a mediating variable (i.e., cognitive performance). If this is also significant, a third regression is run to simultaneously test paths b and c’. Path c’ represents the direct effect of the independent variable on the dependent variable, when controlling for mediating variables. Mediation has occurred with path c’ is no longer significant.

Mediation is said to have occurred if, in the third model, PRT radiation field is no longer a significant predictor of adaptive functioning. All regression models in the current study included covariates, which were identified as demographic and medical variables that differed between the PRT CSI and PRT Focal groups.

We corrected for multiple comparisons using the false discovery rate (FDR) approach and set the FDR threshold at 5%. Associations with p values <0.05 but nonsignificant FDR values are reported as statistical trends. Effect sizes are reported for all comparisons. The following conventions were used to interpret small, medium, and large effect sizes: Cohen’s d (0.2, 0.5, 0.8), Cramer’s V (0.1, 0.3, 0.5), and r (0.1, 0.3, 0.5) (35).

Results

Demographic and clinical characteristics of the sample are reported in Table 1. The sample was balanced with respect to the number of survivors treated with CSI (n = 37) versus Focal (n = 33) PRT. At the time of evaluation, survivors were a mean age of 12.84 years old (range: 5.07–20.94 years) and were 5.40 years post-PRT (range: 1.16–9.89 years). Fifty percent of the sample was White, 30% Hispanic/Latino, 13% Black, and 7% Asian. Spanish was the primary language of five survivors (7.14%) and 11 parents completing questionnaires (15.71%). There were no significant differences on any adaptive functioning domains between parent reporters who spoke English vs. Spanish (all p > 0.05). Similarly, there were no significant differences between Spanish- and English-speaking patients on cognitive index scores (all p > 0.05).

TABLE 1.

Demographics and clinical characteristics

PRT CSI (n = 37)
PRT Focal (n = 33)
n % n % p V


Sex .518 .077
 Male 23 62 18 55
 Female 14 38 15 45
Race/Ethnicity .049 .336
 White 13 35 22 67
 Hispanic/Latino 13 35 8 24
 Black 7 19 2 6
 Asian 4 11 1 3
Histology <.001* .811
 Glioma 1 4 14 42
 Medulloblastoma/ PNET 25 68 3 9
 Ependymoma 0 0 8 24
 Germ Cell Tumor 8 22 2 6
 Craniopharyngioma 0 0 5 15
 Other 3 8 1 3
Tumor Location .168 .226
 Supratentorial 15 41 19 58
 Infratentorial 22 59 13 39
Craniotomy .811 .029
 Yes 33 89 30 91
 No 4 11 3 9
Shunt .130 .181
 Yes 14 38 7 21
 No 23 62 26 79
Lansky/Karnofsky score, ≤70a .079 .222
 Yes 12 36 5 17
 No 21 64 25 83

PRT CSI (n = 37)
PRT Focal (n = 33)
Mdn Range Mdn Range pb r


Total Radiation Dose to Tumor (cGy) 54 45–55.8 50.4 45–60 <.001* .82


M SD M SD p d


Tumor Diameter (cm) 4.90 1.81 4.55 1.70 .415 0.20
Age at Diagnosis (years) 7.50 3.95 5.99 4.12 .123 0.37
Age at Treatment (years) 7.80 3.93 7.04 4.24 .440 0.19
Age at Evaluation (years) 13.00 3.76 12.67 4.78 .743 0.08
Time from RT to Evaluation (years) 5.20 2.76 5.63 2.49 .504 0.16

Note. PRT = proton radiotherapy. CSI = craniospinal irradiation; d = Cohen’s d. PNET = primitive neuroectodermal tumor. V = Cramer’s V, effect size for associations among categorical variables.

a

This value represents the Lansky or Karnofsky score at the first clinic visit following surgical resection, or, if no surgery occurred, the score at the first clinic visit following a brain tumor diagnosis.

b

Mann-Whitney significance test

*

Indicates a statistically significant association (p < .05 and FDR <.05).

Indicates a trend association (p <.05 and FDR >.05).

The PRT CSI and PRT Focal groups were similar for age at diagnosis, treatment, and time of evaluation (all p > .05). Similarly, there were no group differences in sex, time from treatment to evaluation, tumor location (supratentorial vs. infratentorial), impaired functional status at the first clinic visit following diagnosis (e.g., Lansky/Karnofsky score), tumor diameter, history of craniotomy, or history of shunt (all p > .05).

As expected, tumor histology varied significantly between the PRT CSI and PRT Focal groups (ᵡ2(5) = 46.07, p < .001). The proportion of medulloblastoma/PNET tumors was greater in the PRT CSI group, while the proportion of gliomas, ependymomas, and craniopharyngiomas was greater in the PRT Focal group. Additionally, survivors within the PRT CSI group received a significantly higher radiation dose than those in the PRT Focal group (U = 911.50, z = 3.65, p < .001, r = .82). There was a trend toward group differences on race/ethnicity (ᵡ2(3) = 7.88, p = .049), with a higher proportion of White patients represented in the PRT Focal group (67%) compared to the PRT CSI group (35%).

Cognitive Functioning

Cognitive outcomes by group are reported in Table 2. Across all cognitive index scores, performance in the PRT CSI group was worse than normative expectations: FSIQ (t(32) = −4.60, p < .001), VCI (t(33) = −3.52, p = .001), PRI (t(33) = −2.40, p = .022), WMI (t(32) = −3.87, p = .001), and PSI (t(31) = −9.00, p < .001). Similarly, PRT CSI group means were lower than PRT Focal group means across all indexes: FSIQ (t(64) = 2.84, p = .006), VCI (t(65) = 2.64, p = .010), PRI (t(65) = 2.57, p =.013), WMI (t(61) = 2.21, p =.031), and PSI (t(63) = 2.61, p = .011). In contrast, performance in the PRT Focal group did not differ from normative expectations across any index except PSI (t(32) = −4.73, p < .001).

TABLE 2.

Cognitive performance outcomes on Wechsler intelligence scales

PRT CSI (n = 37) PRT Focal (n = 33)


M SD Range CSI vs. Norm p M SD Range Focal vs. Norm p CSI vs. Focal
p d
FSIQ 85.30 18.36 42–127 <.001* 97.76 17.22 44–134 .460 .006* 0.70
VCI 88.79 18.57 50–119 .001* 99.42 13.99 57–132 .815 .010* 0.65
PRI 90.88 22.15 47–147 .022* 103.67 18.38 55–135 .260 .013* 0.63
WMI 87.94 17.92 50–116 .001* 97.60 16.58 52–132 .434 .031* 0.56
PSI 78.03 13.85 50–105 <.001* 87.45 15.23 50–116 <.001* .011* 0.65

Note. CSI = craniospinal irradiation. PRT = proton radiotherapy. FSIQ = Full Scale IQ; VCI = Verbal Comprehension Index; PRI = Perceptual Reasoning Index; WMI = Working Memory Index; PSI = Processing Speed Index. d = Cohen’s d.

*

Indicates a statistically significant association (p < .05 and FDR <.05).

Adaptive Functioning Outcomes

Adaptive functioning outcomes by group are reported in Table 3. Across all adaptive index scores, performance in the PRT CSI group was worse than normative expectations: GAC (t(36) = −5.30, p < .001), Conceptual (t(36) = −4.84, p < .001), Social (t(36) = −4.30, p < .001), Practical (t(36) = −5.41, p < .001). Additionally, PRT CSI group means were lower than PRT Focal group means across the following indexes: Global (t(68) = 2.21, p = .030) and Conceptual (t(68) = 2.78, p = .007). Within the PRT Focal group, performance was worse than normative expectations across the GAC (t(32) = −2.51, p = .018) and Practical (t(32) = −2.89, p = .007) indexes and trended toward below normative performance on the Social index (t(32) = −2.04, p = .049).

TABLE 3.

Adaptive outcomes based on parent ratings on the ABAS

PRT CSI (n = 37) PRT Focal (n = 33)


M SD Range CSI vs. Norm p M SD Range Focal vs. Norm p CSI vs. Focal
p d
GAC 80.85 22.02 41–120 <.001* 91.76 18.90 51–120 .018* .030* 0.53
Conceptual 83.12 21.25 49–120 <.001* 95.73 15.93 59–120 .133 .007* 0.67
Social 86.86 18.58 55–120 <.001* 93.39 18.58 56–120 .049 .147 0.35
Practical 80.03 22.47 40–120 <.001* 89.72 20.39 46–120 .007* .064 0.45

Note. ABAS = Adaptive Behavior Assessment System; CSI = craniospinal irradiation. GAC = Global Adaptive Composite. PRT = proton radiotherapy. d = Cohen’s d.

*

Indicates a statistically significant association (p < .05 and FDR <.05).

Indicates a trend association (p <.05 and FDR >.05).

Correlations between cognitive performance and ABAS ratings by group are shown in Table 4. In both the PRT CSI and PRT Focal groups, performance on all cognitive domains was significantly correlated with global, conceptual, social, and practical adaptive functioning outcomes, with one exception. Within the PRT Focal group, working memory was not correlated with Practical adaptive outcomes. The strongest associations were between FSIQ and Conceptual adaptive skills (PRT CSI: r = .705, p < .001; PRT Focal: r = .686, p < .001) and verbal reasoning and Conceptual adaptive skills (PRT CSI: r = .701, p < .001; PRT Focal: r = .672, p < .001).

TABLE 4.

Correlations between Wechsler cognitive performance and ABAS adaptive outcomes

GAC Conceptual Skills Social Skills Practical Skills

CSI Focal CSI Focal CSI Focal CSI Focal
FSIQ .612** .618** .705** .686** .578** .576** .497* .554**
VCI .575** .616** .701** .672** .501* .581** .460* .528*
PRI .591** .545** .644** .630** .552** .528* .518* .471*
WMI .579** .419* .632** .512* .481* .450* .536** .334
PSI .522* .494* .522* .481* .393* .383* .536* .544**

Note. ABAS = Adaptive Behavior Assessment System; CSI = craniospinal irradiation; GAC = Global Adaptive Composite; FSIQ = Full Scale IQ; VCI = Verbal Comprehension Index; PRI = Perceptual Reasoning Index; WMI = Working Memory Index; PSI = Processing Speed Index.

*

Indicates a statistically significant association (p < .05 and FDR <.05).

**

Indicates a statistically significant association (p ≤ .001and FDR <.05).

Mediation Analyses

The relationships among medical and demographic characteristics, adaptive outcomes, and cognitive performance were further explored using mediation models. An a priori decision was made to use radiation field (CSI vs. Focal) as the predictor of adaptive functioning. Medical and demographic variables were included as covariates if there were significant differences between the PRT CSI and Focal groups. Based on this criteria, covariates included tumor histology and PRT dose.

Radiation field was a significant predictor of Global (B = −11.00, p = .044) and Conceptual (B = −12.49, p = .013) adaptive skills, but not Social (B = −6.20, p = .202) or Practical skills (B = −10.14, p = .073). Consequently, mediation analyses were only completed using Global and Conceptual adaptive domains as dependent variables. Mediating variables included each Wechsler index score (i.e., FSIQ, VCI, PRI, WMI, and PSI).

Table 5 summarizes the results of mediation models. All models resulted in successful mediations; inclusion of cognitive test performance mediated the relationship between radiation field and adaptive functioning outcomes in every analysis, regardless of the domain of cognitive functioning.

TABLE 5.

Cognitive mediators of the relationship between radiation field and the ABAS Global Adaptive Composite and Conceptual Skills Domain

Path a
PRT Field → Cognition
Path b
Cognition → Adaptive Skills
Path c’
PRT Field → Adaptive Skills

B p B P B p

FSIQ −13.05 .008*
 GAC 0.67 <.001** 1.55 .722
 Conceptual 0.71 <.001** 0.05 .989
VCI −11.16 .013*
 GAC 0.70 <.001** −0.32 .943
 Conceptual 0.77 <.001** −1.55 .674
PRI −12.73 .021*
 GAC 0.57 <.001** −1.99 .668
 Conceptual 0.59 <.001** −3.45 .393
WMI −10.57 .028*
 GAC 0.57 <.001** −2.79 .554
 Conceptual 0.60 <.001** −3.65 .383
PSI −10.40 .008*
 GAC 0.70 <.001** 0.81 .863
 Conceptual 0.65 <.001** −1.56 .715

ABAS = Adaptive Behavior Assessment System; PRT = proton radiotherapy; GAC = Global Adaptive Composite; FSIQ = Full Scale IQ; VCI = Verbal Comprehension Index; PRI = Perceptual Reasoning Index; WMI = Working Memory Index; PSI = Processing Speed Index; B = unstandardized regression coefficient

Note. Paths a, b, and c’ represent the three regression models used in each mediation analysis. Path a describes the relationship between radiation field (PRT CSI vs. PRT Focal) and the Wechsler index score. Path b describes the relationship between the Wechsler index score and ABAS adaptive outcomes. Path c’ describes the relationship between radiation field and ABAS adaptive outcomes, when cognitive performance is included in the model. Mediation has occurred when the relationship represented by Path c’ is no longer statistically significant. Covariates included in all regression models were tumor histology and total RT dose.

*

Indicates a statistically significant association (p < .05 and FDR <.05).

**

Indicates a statistically significant association (p ≤ .001 and FDR <.05).

Discussion

This study examined cognitive and adaptive functioning outcomes in a sample of 70 pediatric brain tumor survivors approximately 5-years post-PRT. Overall, survivors receiving focal PRT demonstrated generally positive outcomes, with cognitive and adaptive skills falling broadly within normal limits. The PRT Focal group demonstrated some areas of mild weakness in specific cognitive and adaptive domains. Cognitively, processing speed was a relative weakness. Adaptively, while all scores were within one standard deviation from the mean, relative difficulties were noted specifically with respect to practical and social skills.

In contrast to broadly preserved skills within the PRT Focal group, the PRT CSI group demonstrated more consistent weaknesses. Within the PRT CSI group, all cognitive and adaptive outcomes were significantly worse than normative expectations. Additionally, all cognitive variables and global adaptive skills were found to be significantly worse than survivors within the PRT Focal group. These results are consistent with the broader literature on radiation treatment in pediatric brain tumor survivors and support our hypothesis that individuals treated with CSI PRT are at an increased risk for cognitive and adaptive dysfunction relative to those treated with focal PRT.

Somewhat unexpectedly, the PRT CSI and Focal groups did not differ across all adaptive skills domains. The PRT Focal group demonstrated relative weaknesses related to practical and social skills, and these same areas did not differ statistically from individuals with a history of CSI. Results suggest that all survivors treated with PRT demonstrate some adaptive risk, regardless of radiation field. However, relatively preserved cognitive skill in individuals receiving focal PRT may serve as a protective factor for more cognitively-based adaptive skills (e.g., communication, functional academics, and self-direction).

Results of mediation analyses support a close relationship between cognitive and adaptive outcomes. Mediation models demonstrated that the increased adaptive risk experienced by individuals receiving CSI rather than focal PRT may be due to the negative effects of CSI on cognition. These findings emphasize the continued importance of efforts to reduce the volume, or dose, of radiation to normal brain tissue. Other variables associated with adaptive dysfunction included younger age at the start of PRT, a history of shunt placement, and a Black/African American racial background. The ability to accurately interpret or generalize findings regarding racial/ethnic background is limited given small sample sizes (Black/African American n = 9).

There is limited information regarding adaptive functioning outcomes following PRT in pediatric brain tumor survivors. In the one prior study, adaptive skills were reported to be within the average range three years post-PRT with no significant difference across radiation fields (25). In contrast, results from the current study examining outcomes five years post-PRT on average suggest a higher risk for adaptive dysfunction. Additionally, global adaptive outcomes differed significantly based on radiation field, with survivors who received CSI PRT demonstrating worse outcomes. Divergent findings across studies may be due, in part, to differing measures and/or sampling differences. The sample described by Pulsifer and colleagues (25) was predominantly Caucasian and of a relatively high socioeconomic status, which may have contributed to a higher level of baseline cognitive and adaptive functioning. In contrast, the current study involves a more diverse sample with extended follow-up. In both studies, a close relationship between cognitive and adaptive functioning was described. Given the neurocognitive risks associated with RT, including PRT, and the association between cognitive and adaptive outcomes, it will be important for future studies to continue to investigate and describe adaptive outcomes post-PRT.

While our findings contribute to a better understanding of the functional impact of PRT in the pediatric brain tumor population and suggest generally favorable adaptive outcomes particularly for the focal PRT group, it remains unknown whether these outcomes differ from those experienced by survivors treated with modern photon approaches (e.g., intensity-modulated RT). It is challenging to compare our findings directly to historical reports from photon samples because of differences in instrumentation, sample characteristics (e.g., length of follow-up), and sampling method (e.g., most studies do not report outcomes separately for focal and CSI groups or for irradiated and non-irradiated groups). Well designed, prospective comparative outcomes research is needed to determine the relative benefits of PRT compared to XRT.

This study is unique in our inclusion of Spanish-speaking patients and parents, a group often excluded from outcomes research in this population. While our Spanish-speaking subgroup was small, we did not find differences in outcomes between Spanish- and English-speaking patients (or parents) on cognitive or adaptive outcomes. Consideration of language and culture is important in the examination of late effects (3637). Larger studies with samples that include more racial, ethnic, and cultural diversity are essential to gain a more comprehensive understanding of outcomes and risks in the pediatric brain tumor population.

The current study adds to the literature on outcomes in pediatric brain tumor survivors treated with PRT by describing both cognitive and adaptive functioning across an extended follow-up period of five years. Results demonstrated that cognitive dysfunction likely mediates the relationship between clinical risk factors and adaptive dysfunction. Future directions include determining with greater specificity which aspects of cognition are most closely related to adaptive risk. In the current study, all cognitive variables mediated the relationship between radiation field and adaptive functioning. With a larger sample size, it may become clearer whether specific skills (e.g., processing speed) are differentially influential. The relationship between cognitive functioning and adaptive functioning outcomes reinforce the importance of the Children’s Oncology Group long-term follow-up guidelines recommending cognitive surveillance for pediatric brain tumor survivors (38). Additionally, our findings suggest adaptive functioning assessment should be part of this surveillance for all pediatric brain tumor patients post-RT, regardless of RT modality.

Acknowledgements

Funding for this research was provided, in part, by the National Institutes of Health/National Cancer Institute R01CA187202 (to LSK) and K07CA157923 (to LSK).

Abbreviations Key

RT

Radiotherapy

XRT

X-ray or photon radiotherapy

PRT

Proton radiotherapy

CSI

Craniopsinal irradiation

VCI

Verbal Comprehension Index

PRI

Perceptual Reasoning Index

WMI

Working Memory Index

PSI

Processing Speed Index

FSIQ

Full Scale IQ

ABAS-II or ABAS-3

Adaptive Behavior Assessment System, 2nd Edition or 3rd Edition

GAC

Global Adaptive Composite

FDR

False discovery rate

Footnotes

Conflict of Interest

No authors have any conflicts of interest to declare.

Data Sharing Statement

Research data are not shared.

Reference List

  • 1.Ashford JM, Netson KL, Clark KN, Merchant TE, Santana VM, Wu S, Conklin HM. Adaptive functioning of childhood brain tumor survivors following conformal radiation therapy. J Neurooncol. 2014;118:193–9. 10.1007/s11060-014-1420-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ris MD, Beebe DW, Armstrong FD, Fontanese J, Holmes E, Sanford RA, Wisoff JH, Children’s Oncology Group. Cognitive and adaptive outcome in extracerebellar low-grade brain tumors in children: A report from the Children’s Oncology Group. J Clin Oncol. 2008;26(29):4765–70. 10.1200/JCO.2008.17.1371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Robinson KE, Wolfe KR, Yeates KO, Mahone EM, Cecil KM, Ris MD. Predictors of adaptive functioning and psychosocial adjustment in children with pediatric brain tumor: A report from the Brain Radiation Investigative Study Consortium. Pediatr Blood Cancer. 2015;62(3):509–16. 10.1002/pbc.25323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tassé MJ, Schalock RL, Balboni G, Bersani H Jr, Borthwick-Duffy SA, Spreat S, Thissen D, Widaman KF, Zhang D. The construct of adaptive behavior: Its conceptualization, measurement, and use in the field of intellectual disability. Am J Intellect Dev Disabil. 2012;117(4):291–303. 10.1352/1944-7558-117.4.291 [DOI] [PubMed] [Google Scholar]
  • 5.Gragert MN, Ris MD. Neuropsychological late effects and rehabilitation following pediatric brain tumor. J Pediatr Rehabil Med. 2011;4(1):47–58. 10.3233/PRM-2011-0153 [DOI] [PubMed] [Google Scholar]
  • 6.Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5(7):399–408. 10.1016/S1470-2045(04)01507-4 [DOI] [PubMed] [Google Scholar]
  • 7.Stargatt R, Rosenfeld JV, Anderson V, Hassall T, Maixner W, Ashley D. Intelligence and adaptive function in children diagnosed with brain tumour during infancy. J Neurooncol. 2006;80(3):295–303. 10.1007/s11060-006-9187-0 [DOI] [PubMed] [Google Scholar]
  • 8.Clark KN, Ashford JM, Panandiker ASP, Klimo P, Merchant TE, Bilups CA, Conklin HM. Cognitive outcomes among survivors of focal low-grade brainstem tumors diagnosed in childhood. J Neurooncol 2016;129(2):311–7. 10.1007/s11060-016-2176-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vern-Gross TZ, Schreiber JE, Broniscer A, Wu S, Xiong X, Merchant TE. Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma. Neuro Oncol. 2014;16(12):1652–60. 10.1093/neuonc/nou101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies CCG 9891/POG 9130. J Clin Oncol. 2005;23(22)5198–204. 10.1200/JCO.2005.06.117 [DOI] [PubMed] [Google Scholar]
  • 11.Hoskinson KR, Wolfe KR, Yeats KO, Mahone EM, Cecil KM, Ris MD. Predicting changes in adaptive functioning and behavioral adjustment following treatment for a pediatric brain tumor: A report from the Brain Radiation Investigative Study Consortium. Psycho-Oncol. 2018;27(1),178–186. 10.1002/pon.4394 [DOI] [PubMed] [Google Scholar]
  • 12.Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE. Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Rad Oncol Biol Phys. 2013;85(5):1301–6. 10.1016/j.ijrobp.2012.10.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Robinson KE, Wolfe KR, Yeates KO, Mahone EM, Cecil KM, Ris MD. Predictors of adaptive functioning and psychosocial adjustment in children with pediatric brain tumor: A report from the brain radiation investigative study consortium. Pediatr Blood Cancer. 2015;62(3):509–16. 10.1002/pbc.25323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kunin-Batson A, Kadan-Lottick N, Zhu L, Cox C, Bordes-Edar V, Srivastava DK, Zeltzer L, Robison LL, Krull KR. Predictors of independent living status in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57(7):1197–203. 10.1002/pbc.22982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.King TZ, Smith KM, Ivanisevic M. The mediating role of visuospatial planning skills on adaptive function among young-adult survivors of childhood brain tumor. Arch Clin Neuropsychol. 2015;30(5):394–403. 10.1093/arclin/acv033 [DOI] [PubMed] [Google Scholar]
  • 16.Shultz EL, Hoskinson KR, Keim MC, Dennis M, Taylor HG, Bigler ED, Rubin KH, Vannatta K, Gerhardt CA, Stancin T, Yeates KO. Adaptive functioning following pediatric traumatic brain injury: Relationship to executive function and processing speed. Neuropsychology. 2016;30(7):830–40. 10.1037/neu0000288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Treble-Barna A, Zang H, Zhang N, Taylor HG, Yeates KO, Wade S. Long-term neuropsychological profiles and their role as mediators of adaptive functioning after traumatic brain injury in early childhood. J Neurotrauma. 2017;34(2):353–362. 10.1089/neu.2016.4476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Antonini TN, Ris MD, Grosshans DR, Mahajan A, Okcu MF, et al. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017;124(1):89–97. 10.1016/j.radonc.2017.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, Yock TI. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014;89(5):1060–1068. 10.1016/j.ijrobp.2014.04.053 [DOI] [PubMed] [Google Scholar]
  • 20.Kahalley LS, Ris MD, Grosshans DR, Okcu MF, Paulino AC, Chintagumpala M, Moore BD, Guffey D, Minard CG, Stancel HH, Mahajan A. Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors. J Clin Oncol. 2016;34(10):1043–9. 10.1200/JCO.2015.62.1383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kahalley LS, Ris MD, Mahajan A, Okcu MF, Chintagumpala M, Paulino AC, Whitehead WE, Minard CG, Stancel HH, Orobio J, Xue JJ, Warren EA, Grosshans DR. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019;21(6):809–818. 10.1093/neuonc/noz041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pulsifer MB, Sethi RV, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI. Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors. Int J Radiat Oncol Biol Phys. 2015;93(2):400–7. 10.1016/j.ijrobp.2015.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: A phase 2 single-arm study. Lancet Oncol. 2016;17(3):287–98. 10.1016/S1470-2045(15)00167-9 [DOI] [PubMed] [Google Scholar]
  • 24.Zureick AH, Evans CL, Niemierko A, Grieco JA, Nichols AJ, Fullerton BC, Hess CB, Goebel CP, Gallotto SL, Weyman EA, Gaudet DE, Nartowicz JA, Ebb DH, Jones RM, MacDonald SM, Tarbell NJ, Yock TI, Pulsifer MB. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer. 2018;124(10):2238–2245. 10.1002/cncr.31143 [DOI] [PubMed] [Google Scholar]
  • 25.Pulsifer MB, Duncanson H, Grieco J, Evans C, Tseretopoulos ID, MacDonald S, Tarbell NJ, Yock TI. Cognitive and adaptive outcomes after proton radiation for pediatric patients with brain tumors. Int J Radiat Oncol Biol Phys. 2018;102(2):391–398. 10.1016/j.ijrobp.2018.05.069 [DOI] [PubMed] [Google Scholar]
  • 26.Wechsler D Wechsler Preschool and Primary Scale of Intelligence, Third Edition. San Antonio, TX: The Psychological Corporation; 2002. [Google Scholar]
  • 27.Wechsler D Wechsler Intelligence Scale for Children, Fourth Edition. San Antonio, TX: The Psychological Corporation; 2003. [Google Scholar]
  • 28.Wechsler D Wechsler Intelligence Scale for Children, Fourth Edition-Spanish. San Antonio, TX: The Psychological Corporation; 2005. [Google Scholar]
  • 29.Wechsler D Wechsler Intelligence Scale for Children, Fifth Edition. San Antonio, TX: The Psychological Corporation; 2014. [Google Scholar]
  • 30.Wechsler D Wechsler Adult Intelligence Scale, Fourth Edition. San Antonio, TX: The Psychological Corporation; 2008. [Google Scholar]
  • 31.Wechsler D Escala de Inteligencia Wechsler Para Adultos, Tercera Edición (EIWA-III). San Antonio, TX: Pearson; 2008. [Google Scholar]
  • 32.Harrison P, Okland T. Adaptive Behavior Assessment System, Second Edition. San Antonio, TX: Harcourt Assessment; 2003. [Google Scholar]
  • 33.Harrison PL, Okland T Adaptive Behavior Assessment System, Third Edition. Torrance, CA: Western Psychological Services; 2015. [Google Scholar]
  • 34.Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82. [DOI] [PubMed] [Google Scholar]
  • 35.Cohen J Statistical power analysis for the behavioral sciences, 2nd ed. Hillsday, NJ: Erlbaum; 1988. [Google Scholar]
  • 36.Patel SK, Tracy TYL, Dennis JM, Bhatia, S. Neurocognitive and behavioral outcomes in Latino childhood cancer survivors. Pediatr Blood Cancer. 2013;60(10):1696–1702. 10.1002/pbc.24608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Raghubar KP, Orobio J, Ris MD, Heitzer AM, Roth A, Brown AL, Okcu MF, Chintagumpala M, Grosshans DR, Paulino AC, Mahajan A, Kahalley LS. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatric Blood Cancer. 2019;66(9):e27800 10.1002/pbc.27800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent And Young Adult Cancers, Version 5.0. Monrovia, CA: Children’s Oncology Group; October 2018. Available online: www.survivorshipguidelines.org [Google Scholar]

RESOURCES